Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on July 30, 2025
Bitcoin Swift Announces Stage 2 Presale and AI-Driven Governance Rollout Ahead of 2026 Ecosystem Launch
GlobeNewswire
·
July 30, 2025
LUXEMBOURG, July 30, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3) a next-generation decentralized financial protocol, has officially entered Stage 2 of its limited 64-day presale, offering early access to its programmable staking rewards and upcoming …
Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025
GlobeNewswire
·
July 30, 2025
BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, announced today that clinical data …
Amerigo Announces Q2-2025 Results & Quarterly Dividend
GlobeNewswire
·
July 30, 2025
Q2-2025 Net Income of $7.5 million Robust EBITDA1 of $17.8 million and Free Cash Flow to Equity1 of $6.5 million 16th Consecutive Quarterly Dividend of Cdn$0.03 Declared $7.6 million Returned through Dividends and Share Buybacks in Q2-2025 VANCOUVER, …
Diana Shipping Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2025; Declares Cash Dividend of $0.01 Per Common Share for the Second Quarter 2025
GlobeNewswire
·
July 30, 2025
ATHENS, Greece, July 30, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today reported net income of $4.5 million and net …
Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress
GlobeNewswire
·
July 30, 2025
LONDON and PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing innovative, targeted oncology drugs, today announces that the Company will present an updated data analysis from …
NexGold Intersects 40.09 g/t gold over 17.7 Metres at the Goldboro Open Pit Gold Project
GlobeNewswire
·
July 30, 2025
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …
HPQ Introduces Endura: Its First Commercial Battery Brand Built on GEN3 Technology
GlobeNewswire
·
July 30, 2025
MONTREAL, July 30, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology innovator in advanced materials and critical process development, is pleased to announce the launch of its new …
HPQ lance Endura, sa première marque de batteries commerciales propulsée par la technologie GEN3
GlobeNewswire
·
July 30, 2025
MONTRÉAL, 30 juill. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), un innovateur technologique dans le développement de matériaux avancés et de procédés critiques, HPQ est fier d’annoncer le …
IRSA: Lighting Up the Future, Connecting the World Yarlung Tsangpo Hydropower Project Breaks Ground, Marking a New Pinnacle in China’s Mega Infrastructure
GlobeNewswire
·
July 30, 2025
New York, July 30, 2025 (GLOBE NEWSWIRE) -- According to International Relations Study Association(IRSA), on July 19, 2025, in Motuo County, a remote border town in Nyingchi, Tibet Autonomous Region of China, a single blast announced a feat destined to …
Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein
GlobeNewswire
·
July 30, 2025
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025: Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten zur Behandlung …
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
GlobeNewswire
·
July 30, 2025
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative …
Atos reconnu Supplier Engagement Leader par le CDP pour la 5ème fois
GlobeNewswire
·
July 30, 2025
Communiqué de presse Atos reconnu Supplier Engagement Leader par le CDP pour la 5ème fois Paris, France – 30 juillet 2025 – Atos intègre, pour la 5ème fois, le prestigieux classement Supplier Engagement Rating …
Atos recognized as Supplier Engagement Leader by CDP for the 5th time
GlobeNewswire
·
July 30, 2025
Press Release Atos recognized as Supplier Engagement Leader by CDP for the 5th time Paris, France – July 30, 2025 – Atos has been recognized for the fifth time by the Carbon Disclosure …
Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre
GlobeNewswire
·
July 30, 2025
VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, is pleased to …
Wolters Kluwer 2025 Half-Year Report
GlobeNewswire
·
July 30, 2025
Wolters Kluwer 2025 Half-Year Report Alphen aan den Rijn, July 30, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its half-year 2025 results. Highlights Guidance for 2025 updated. (See …
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
GlobeNewswire
·
July 30, 2025
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY APPROVAL FROM EUROPEAN COUNTRIES TO INITIATE THIRD STAGE OF PHASE I/II STUDY COMBINING ITS MOLECULE AB8939 WITH VENETOCLAX FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA THE COMBINATION OF AB8939 TARGETING …
AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA
GlobeNewswire
·
July 30, 2025
COMMUNIQUÉ DE PRESSE AB SCIENCE A RECU L’APPROBATION REGLEMENTAIRE DE PAYS EUROPEENS POUR INITIER LA TROISIEME ETAPE DE LA PHASE I/II VISANT A COMBINER SA MOLÉCULE AB8939 AVEC LE VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË LA COMBINAISON D’ …
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
GlobeNewswire
·
July 30, 2025
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Proposed transaction would seamlessly align with Sandoz strategic objective of capitalizing on projected USD 300 billion biosimilar market opportunity over next 10 years …
Ascom has signed up SEC-COM to become a new distribution partner in Germany
GlobeNewswire
·
July 30, 2025
Baar, Switzerland, July 30, 2025 The two technology providers have signed a multimillion-euro framework contract of Ascom solutions. SEC-COM Security and Communication Technology GmbH is one of the leading IT and telecommunication providers in Germany, …
SEC-COM wird neuer Vertriebspartner von Ascom in Deutschland
GlobeNewswire
·
July 30, 2025
Baar, Schweiz, 30. Juli, 2025 Die beiden Informations- und Kommunikationstechnik Systemanbieter schließen einen Rahmenvertrag mit einer Absatzgarantie von Ascom Lösungen über mehrere Millionen Euro ab. SEC-COM Security and Communication Technology GmbH ist …